Impact of Vaccination Status on Outcome of Patients With COVID‐19 and Acute Ischemic Stroke Undergoing Mechanical Thrombectomy
Authors:
- Cornelius DeuschlCDCornelius Deuschl
- Lukas GoertzLGLukas Goertz
- Christoph KabbaschCKChristoph Kabbasch
- Christoph KleinschnitzChristoph Kleinschnitz
- Ansgar BerlisABAnsgar Berlis
- Christoph Johannes MaurerCMChristoph Johannes Maurer
- Iris MühlenIMIris Mühlen
- Bernd KallmünzerBKBernd Kallmünzer
- Matthias GawlitzaMGMatthias Gawlitza
- Daniel P. O. KaiserDKDaniel P. O. Kaiser
Open Access
- 7 May 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (9) , e031816
Abstract
Background: Data on impact of COVID‐19 vaccination and outcomes of patients with COVID‐19 and acute ischemic stroke undergoing mechanical thrombectomy are scarce. Addressing this subject, we report our multicenter experience. Methods and Results: This was a retrospective analysis of patients with COVID‐19 and known vaccination status treated with mechanical thrombectomy for acute ischemic stroke at 20 tertiary care centers between January 2020 and January 2023. Baseline demographics, angiographic outcome, and clinical outcome evaluated by the modified Rankin Scale score at discharge were noted. A multivariate analysis was conducted to test whether these variables were associated with an unfavorable outcome, defined as modified Rankin Scale score >3. A total of 137 patients with acute ischemic stroke (48 vaccinated and 89 unvaccinated) with acute or subsided COVID‐19 infection who underwent mechanical thrombectomy attributable to vessel occlusion were included in the study. Angiographic outcomes between vaccinated and unvaccinated patients were similar (modified Thrombolysis in Cerebral Infarction ≥2b: 85.4% in vaccinated patients versus 86.5% in unvaccinated patients; P =0.859). The rate of functional independence (modified Rankin Scale score, ≤2) was 23.3% in the vaccinated group and 20.9% in the unvaccinated group ( P =0.763). The mortality rate was 30% in both groups. In the multivariable analysis, vaccination status was not a significant predictor for an unfavorable outcome ( P =0.957). However, acute COVID‐19 infection remained significant (odds ratio, 1.197 [95% CI, 1.007–1.417]; P =0.041). Conclusions: Our study demonstrated no impact of COVID‐19 vaccination on angiographic or clinical outcome of COVID‐19–positive patients with acute ischemic stroke undergoing mechanical thrombectomy, whereas worsening attributable to COVID‐19 was confirmed.Keywords
This publication has 18 references indexed in Scilit:
- The Effect of COVID-19 Vaccines on Stroke Outcomes: A Single-Center StudyWorld Neurosurgery, 2022
- Mechanical thrombectomy for acute ischemic stroke in COVID-19 patients: multicenter experience in 111 casesJournal of NeuroInterventional Surgery, 2022
- Effect of Thrombectomy With Combined Contact Aspiration and Stent Retriever vs Stent Retriever Alone on Revascularization in Patients With Acute Ischemic Stroke and Large Vessel OcclusionJAMA, 2021
- SARS-CoV-2 Vaccine–Induced Immune Thrombotic ThrombocytopeniaNew England Journal of Medicine, 2021
- Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control studyBMJ, 2021
- Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY ConsortiumJAMA Network Open, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineNew England Journal of Medicine, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance studyThe Lancet Psychiatry, 2020
- Regression Modeling Strategies2001